Dosed the first patient in the Phase 2 Elumina trial of VLS-01 (buccal film DMT) for patients with treatment-resistant depression; topline ...

The patent is based on preclinical trial results led by Professor Gal Yadid and his team at the Gonda Multidisciplinary Brain Research Center at Bar-Ilan University in Israel. These results followed ...

Shares of GH Research PLC (NASDAQ:GHRS – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms ...

GH Research PLC (NASDAQ:GHRS – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $10.55, but opened at $10.99. GH Research shares last traded at $10.81, ...

The treatment incorporates Clearmind’s 5-methoxy-2-aminoindane (MEAI ... SciSparc's Annual Report on Form 20-F filed with the SEC on April 1, 2024, and in subsequent filings with the U.S ...

This assay was used to guide the fractionation of this extract and allowed the isolation of four compounds: the new naphthoquinone eleutherinone[8-methoxy-1-methyl-1,3-dihydro-naphtho(2,3-c)furan-4,9 ...

SciSparc Ltd (NASDAQ:SPRC) shares are ripping higher Monday after the company announced that its collaboration with Clearmind ...

Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for many aggressive cancers, including breast, lung, ovarian, pancreatic, bladder ...

Cabinet has agreed to progress stronger controls on 23 harmful substances, including the classification of three substances ...

The CBSE Class 12 Chemistry Exam 2025 is set for February 27, 2025, and as the exam approaches, strategic revision is crucial for scoring high marks. To assist students in their last-minute ...